Xvivo Perfusion AB (publ) (LON: 0RKL)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	968	810	435	671	804	365
Market Cap Growth	82.11%	86.41%	-35.22%	-16.57%	120.04%	18.78%
Enterprise Value	937	766	410	648	751	350
Last Close Price	30.94	25.72	14.78	22.75	28.27	13.00
PE Ratio	64.43	113.04	296.26	1007.77	-	915.59
PS Ratio	21.44	17.37	13.15	31.79	50.14	20.48
PB Ratio	7.73	5.34	3.82	6.39	8.94	7.83
P/TBV Ratio	11.03	7.84	6.86	10.06	11.59	8.95
P/FCF Ratio	-	3172.09	564.50	-	-	237.98
P/OCF Ratio	239.05	224.23	195.98	-	-	153.27
EV/Sales Ratio	16.93	16.42	12.40	30.71	46.80	19.61
EV/EBITDA Ratio	134.96	515.41	387.15	-	-	368.87
EV/EBIT Ratio	219.23	1818.08	1156.31	-	-	1090.62
EV/FCF Ratio	-26421.13	2998.27	532.54	-	-	227.92
Debt / Equity Ratio	0.01	0.02	0.01	0.00	0.01	0.01
Debt / EBITDA Ratio	0.26	1.06	0.51	-	-	0.37
Debt / FCF Ratio	-	9.61	1.03	-	-	0.29
Asset Turnover	0.33	0.30	0.25	0.19	0.20	0.36
Inventory Turnover	1.14	1.23	1.29	1.02	0.97	1.45
Quick Ratio	4.23	4.94	2.60	4.43	5.51	3.97
Current Ratio	5.49	6.14	3.47	5.24	6.41	4.94
Return on Equity (ROE)	10.18%	5.44%	1.36%	0.71%	-5.52%	0.88%
Return on Assets (ROA)	1.60%	0.17%	0.17%	-0.87%	-3.09%	0.41%
Return on Capital (ROIC)	1.78%	0.20%	0.20%	-1.02%	-3.45%	0.44%
Earnings Yield	1.55%	0.88%	0.34%	0.10%	-0.48%	0.11%
FCF Yield	-0.00%	0.03%	0.18%	-0.27%	-0.17%	0.42%
Buyback Yield / Dilution	-4.55%	-1.39%	-2.04%	-6.49%	-1.39%	-1.89%
Total Shareholder Return	-4.55%	-1.39%	-2.04%	-6.49%	-1.39%	-1.89%

Source: S&P Capital IQ. Standard template. Financial Sources.